<div class="container">

<table style="width: 100%;"><tr>
<td>certolizumab</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Trials of certolizumab pegol (CZP) for the treatment of rheumatoid arthritis in patients</h2>

<h3>Description</h3>

<p>A dataset of 12 trials for investigating CZP for the treatment for those who had failed on disease-modifying antirheumatic drugs, including methotrexate (MTX).
Data provides the number of patients who have improved and there are 6 different treatments with placebo. Mean disease duration (years) is provided as a covariate.
</p>


<h3>Usage</h3>

<pre><code class="language-R">certolizumab
</code></pre>


<h3>Format</h3>

<p>A list of Outcomes, Treat, Study, N, covariate, and Treat.order
</p>


<h3>References</h3>

<p>S. Dias, A.J. Sutton, A.E. Ades, and N.J. Welton (2013b), <em>Heterogeneity-Subgroups, Meta-Regression, Bias, and Bias-Adjustment</em>, Medical Decision Making 33(5):618-640. <a href="https://doi.org/10.1177/0272989X13485157">doi:10.1177/0272989X13485157</a>
</p>


</div>